glp-1 receptor agonists and cardiovascular outcome trials an update

glp-1 receptor agonists and cardiovascular outcome trials an update Glucagon-like peptide 1 agonists: benefits mechanisms of action Real-World Evidence for GLP-1 Receptor

Name: glp-1 receptor agonists and cardiovascular outcome trials an update Glucagon-like peptide 1 agonists: benefits mechanisms of action Real-World Evidence for GLP-1 Receptor
Brand: 2m-capital.com
SKU: 9721377899
Price: 28.46 USD
Availability: InStock
Rating: 4.4239 (6 reviews)

SKU: 9721377899

4.4

USD28.46 USD61.46

Pay in 4 interest-free payments of $7.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 14 - Nov 19

Description

Adzic M, Djordjevic J, Djordjevic A, Niciforovic A, Demonacos C, Radojcic M, et al

The complexity of NF-B signaling in inflammation and cancer

& Delgado, R

Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): phase 3 study results [Abstract]